应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LFCR LIFECORE BIOMEDICAL INC
交易中 01-13 14:06:49 EST
7.54
-0.05
-0.66%
最高
7.63
最低
7.40
成交量
7.33万
今开
7.59
昨收
7.59
日振幅
3.03%
总市值
2.82亿
流通市值
1.43亿
总股本
3,747万
成交额
54.79万
换手率
0.39%
流通股本
1,902万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Lifecore Biomedical与新大型跨国制药客户签署CDMO主服务协议
美股速递 · 2025-12-17
Lifecore Biomedical与新大型跨国制药客户签署CDMO主服务协议
Lifecore Biomedical将注射药品的商业生产从当前制造商转移到公司设施
美股速递 · 2025-10-29
Lifecore Biomedical将注射药品的商业生产从当前制造商转移到公司设施
Lifecore与Polypeptide宣布合作,旨在为美国市场提供全面的肽生产解决方案
美股速递 · 2025-10-28
Lifecore与Polypeptide宣布合作,旨在为美国市场提供全面的肽生产解决方案
Lifecore Biomedical, Inc.盘中异动 早盘股价大涨7.84%
市场透视 · 2025-10-13
Lifecore Biomedical, Inc.盘中异动 早盘股价大涨7.84%
Lifecore Biomedical, Inc.盘中异动 股价大跌5.03%报6.70美元
市场透视 · 2025-09-25
Lifecore Biomedical, Inc.盘中异动 股价大跌5.03%报6.70美元
Lifecore Biomedical, Inc.盘中异动 早盘大幅下跌5.22%
市场透视 · 2025-08-08
Lifecore Biomedical, Inc.盘中异动 早盘大幅下跌5.22%
Lifecore Biomedical, Inc.盘中异动 急速上涨5.38%报7.64美元
市场透视 · 2025-08-07
Lifecore Biomedical, Inc.盘中异动 急速上涨5.38%报7.64美元
Lifecore Biomedical, Inc.盘中异动 股价大涨5.01%报7.34美元
市场透视 · 2025-08-05
Lifecore Biomedical, Inc.盘中异动 股价大涨5.01%报7.34美元
Lifecore Biomedical, Inc.盘中异动 大幅下挫5.02%
市场透视 · 2025-07-16
Lifecore Biomedical, Inc.盘中异动 大幅下挫5.02%
Lifecore Biomedical, Inc.盘中异动 急速拉升6.43%
市场透视 · 2025-02-25
Lifecore Biomedical, Inc.盘中异动 急速拉升6.43%
Lifecore Biomedical, Inc.盘中异动 股价大跌5.06%报6.00美元
市场透视 · 2025-01-28
Lifecore Biomedical, Inc.盘中异动 股价大跌5.06%报6.00美元
Lifecore Biomedical, Inc.盘中异动 股价大跌5.13%报6.10美元
市场透视 · 2025-01-24
Lifecore Biomedical, Inc.盘中异动 股价大跌5.13%报6.10美元
Lifecore Biomedical, Inc.盘中异动 股价大涨5.00%报6.09美元
市场透视 · 2025-01-10
Lifecore Biomedical, Inc.盘中异动 股价大涨5.00%报6.09美元
Lifecore Biomedical, Inc.盘中异动 大幅下挫5.82%报6.47美元
市场透视 · 2025-01-07
Lifecore Biomedical, Inc.盘中异动 大幅下挫5.82%报6.47美元
Lifecore Biomedical(LFCR.O):2025年Q2营收3260万美元,净亏损660万美元,实施增长战略,产能翻倍至3亿美元
市场资讯 · 2025-01-07
Lifecore Biomedical(LFCR.O):2025年Q2营收3260万美元,净亏损660万美元,实施增长战略,产能翻倍至3亿美元
Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.25%
市场透视 · 2025-01-06
Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.25%
Lifecore Biomedical(LFCR.O):2025年Q2营收3260万美元,同比增长8%,完成股票发行增强流动性
市场资讯 · 2025-01-06
Lifecore Biomedical(LFCR.O):2025年Q2营收3260万美元,同比增长8%,完成股票发行增强流动性
Lifecore Biomedical, Inc.盘中异动 股价大涨6.46%报7.09美元
市场透视 · 2025-01-03
Lifecore Biomedical, Inc.盘中异动 股价大涨6.46%报7.09美元
Lifecore Biomedical(LFCR.US):2025年Q2财报实现营收3256.4万美元,前值为3015万美元,预期值为2975万美元;每股收益为-0.25美元,前值为0.39美元,预期值为-0.31美元。
金融界 · 2025-01-03
Lifecore Biomedical(LFCR.US):2025年Q2财报实现营收3256.4万美元,前值为3015万美元,预期值为2975万美元;每股收益为-0.25美元,前值为0.39美元,预期值为-0.31美元。
Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29),销售额$3260万高于预期$2975万
财报速递 · 2025-01-03
Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29),销售额$3260万高于预期$2975万
加载更多
公司概况
公司名称:
LIFECORE BIOMEDICAL INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lifecore Biomedical, Inc.于1986年10月31日在加利福尼亚州注册成立,并于2008年11月6日重新注册为特拉华州公司。该公司及其子公司为食品和生物材料市场设计、开发、制造和销售差异化产品,并向合作伙伴许可技术应用。
发行价格:
--
{"stockData":{"symbol":"LFCR","market":"US","secType":"STK","nameCN":"LIFECORE BIOMEDICAL INC","latestPrice":7.54,"timestamp":1768331185671,"preClose":7.59,"halted":0,"volume":73293,"delay":0,"floatShares":19024455,"shares":37466352,"eps":-1.273991,"marketStatus":"交易中","change":-0.05,"latestTime":"01-13 14:06:49 EST","open":7.59,"high":7.63,"low":7.4,"amount":547871.7420528,"amplitude":0.030303,"askPrice":7.55,"askSize":240,"bidPrice":7.52,"bidSize":333,"shortable":3,"etf":0,"ttmEps":-1.273991,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"listingDate":824274000000,"exchange":"NASDAQ","adjPreClose":7.59,"postHourTrading":{"tag":"盘后","latestPrice":7.59,"preClose":7.59,"latestTime":"16:10 EST","volume":1576,"amount":11963.84,"timestamp":1768252204209},"volumeRatio":0.891261,"impliedVol":0.8011,"impliedVolPercentile":0.4064},"requestUrl":"/m/hq/s/LFCR","defaultTab":"news","newsList":[{"id":"1184255114","title":"Lifecore Biomedical与新大型跨国制药客户签署CDMO主服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1184255114","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184255114?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:06","pubTimestamp":1765973168,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical与新大型跨国制药客户签署CDMO主服务协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","LFCR","BK4121"],"gpt_icon":0},{"id":"1189952474","title":"Lifecore Biomedical将注射药品的商业生产从当前制造商转移到公司设施","url":"https://stock-news.laohu8.com/highlight/detail?id=1189952474","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189952474?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:27","pubTimestamp":1761737255,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical将注射药品的商业生产从当前制造商转移到公司设施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4212","LFCR"],"gpt_icon":0},{"id":"1108684378","title":"Lifecore与Polypeptide宣布合作,旨在为美国市场提供全面的肽生产解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1108684378","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108684378?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:02","pubTimestamp":1761649361,"startTime":"0","endTime":"0","summary":"Lifecore与Polypeptide宣布合作,旨在为美国市场提供全面的肽生产解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4212","LFCR"],"gpt_icon":0},{"id":"2575404910","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大涨7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575404910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575404910?lang=zh_cn&edition=full","pubTime":"2025-10-13 21:30","pubTimestamp":1760362229,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日21时30分,Lifecore Biomedical, Inc.股票出现异动,股价大幅上涨7.84%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为0.00%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc 是一家完全集成的合同开发和制造组织 ,提供注射器、西林瓶和药筒等复杂无菌注射剂产品的开发、灌装和成品服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213029a6b7306b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213029a6b7306b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","BK4139","CDMO","LFCR"],"gpt_icon":0},{"id":"2570180047","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.03%报6.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570180047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570180047?lang=zh_cn&edition=full","pubTime":"2025-09-25 21:58","pubTimestamp":1758808708,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日21时58分,Lifecore Biomedical, Inc.股票出现异动,股价大幅下跌5.03%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体跌幅为0.56%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc 是一家完全集成的合同开发和制造组织 ,提供注射器、西林瓶和药筒等复杂无菌注射剂产品的开发、灌装和成品服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925215828a69ddbcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925215828a69ddbcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","LFCR","BK4139","CDMO"],"gpt_icon":0},{"id":"2557735265","title":"Lifecore Biomedical, Inc.盘中异动 早盘大幅下跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557735265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557735265?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:41","pubTimestamp":1754664088,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时41分,Lifecore Biomedical, Inc.股票出现异动,股价急速下挫5.22%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体跌幅为0.88%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808224129a6db3c1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808224129a6db3c1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","BK4212","CDMO","BK4139","BK4121"],"gpt_icon":0},{"id":"2557309438","title":"Lifecore Biomedical, Inc.盘中异动 急速上涨5.38%报7.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557309438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557309438?lang=zh_cn&edition=full","pubTime":"2025-08-07 01:28","pubTimestamp":1754501295,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日01时28分,Lifecore Biomedical, Inc.股票出现异动,股价大幅上涨5.38%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体跌幅为2.21%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807012816a6d70485&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807012816a6d70485&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","BK4121","BK4139","LFCR","CDMO"],"gpt_icon":0},{"id":"2557335466","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.01%报7.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557335466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557335466?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:14","pubTimestamp":1754331282,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时14分,Lifecore Biomedical, Inc.股票出现异动,股价大幅上涨5.01%。截至发稿,该股报7.34美元/股,成交量5.8804万股,换手率0.16%,振幅5.72%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为0.46%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502144294cf6170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502144294cf6170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","BK4139","CDMO","LFCR"],"gpt_icon":0},{"id":"2551191745","title":"Lifecore Biomedical, Inc.盘中异动 大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551191745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551191745?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:26","pubTimestamp":1752603982,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日02时26分,Lifecore Biomedical, Inc.股票出现异动,股价大幅下跌5.02%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体跌幅为2.26%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716022622a6abaf6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716022622a6abaf6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","BK4121","BK4212","BK4139","CDMO"],"gpt_icon":0},{"id":"2514090138","title":"Lifecore Biomedical, Inc.盘中异动 急速拉升6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090138?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:37","pubTimestamp":1740494269,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时37分,Lifecore Biomedical, Inc.股票出现波动,股价大幅上涨6.43%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为1.46%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522374998924e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522374998924e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","LFCR","BK4139","CDMO"],"gpt_icon":0},{"id":"2506568588","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.06%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506568588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506568588?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:27","pubTimestamp":1737998821,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时27分,Lifecore Biomedical, Inc.股票出现异动,股价快速下跌5.06%。截至发稿,该股报6.00美元/股,成交量3.105万股,换手率0.08%,振幅5.06%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为2.25%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128012701a2318e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128012701a2318e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","BK4139","CDMO","TKNO","BK4539","BK4121","LFCR"],"gpt_icon":0},{"id":"2505432023","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.13%报6.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505432023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505432023?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:22","pubTimestamp":1737663720,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时22分,Lifecore Biomedical, Inc.股票出现波动,股价快速下挫5.13%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为0.69%。其相关个股中,Cbdmd, Inc.、阿玛琳、Eton Pharmaceuticals, Inc.涨幅较大,Cbdmd, Inc.、Inmed Pharmaceuticals Inc.、Painreform Ltd.较为活跃,换手率分别为48.53%、34.22%、19.86%,振幅较大的相关个股有Cbdmd, Inc.、Petros Pharmaceuticals, Inc.、Gelteq Limited,振幅分别为26.13%、19.84%、18.55%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042200a22d4db6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042200a22d4db6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LFCR","CDMO","BK4212","BK4139"],"gpt_icon":0},{"id":"2502862870","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.00%报6.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502862870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502862870?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分,Lifecore Biomedical, Inc.股票出现异动,股价快速拉升5.00%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为0.10%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223217aba602bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223217aba602bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO","BK4212","BK4121","LFCR"],"gpt_icon":0},{"id":"2501778863","title":"Lifecore Biomedical, Inc.盘中异动 大幅下挫5.82%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501778863?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:42","pubTimestamp":1736260959,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时42分,Lifecore Biomedical, Inc.股票出现异动,股价大幅下挫5.82%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为0.23%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224239aba1e1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224239aba1e1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CDMO","BK4139","BK4121","LFCR","PTPI","BK4212"],"gpt_icon":0},{"id":"2501129643","title":"Lifecore Biomedical(LFCR.O):2025年Q2营收3260万美元,净亏损660万美元,实施增长战略,产能翻倍至3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501129643","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501129643?lang=zh_cn&edition=full","pubTime":"2025-01-07 06:41","pubTimestamp":1736203260,"startTime":"0","endTime":"0","summary":"01. Lifecore Biomedical(LFCR.O)业绩电话会:2025年Q2,公司营收3260万美元,同比增长8%,毛利润1110万美元,增加110万美元。销售管理费用1110万美元,净亏损660万美元。上半年营收5730万美元,增长5%,毛利润1650万美元,增加380万美元。净亏损2280万美元。公司实施增长战略,目标12%营收复合年增长,EBITDA利润率超25%。业务开发管道增长,与大型跨国公司合作增多。产能翻倍至3亿美元,任命新高管以降低成本、保持品质。毛利率预计全年约30%,债务约1.6亿美元。\n\n\n\n\n\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-07/doc-ineeautf2488693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFCR"],"gpt_icon":0},{"id":"2501256265","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501256265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501256265?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:11","pubTimestamp":1736176315,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时11分,Lifecore Biomedical, Inc.股票出现波动,股价快速下挫5.25%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体跌幅为0.30%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106231156985cef7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106231156985cef7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LFCR","BK4212","BK4121","CDMO"],"gpt_icon":0},{"id":"2501244089","title":"Lifecore Biomedical(LFCR.O):2025年Q2营收3260万美元,同比增长8%,完成股票发行增强流动性","url":"https://stock-news.laohu8.com/highlight/detail?id=2501244089","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501244089?lang=zh_cn&edition=full","pubTime":"2025-01-06 06:41","pubTimestamp":1736116860,"startTime":"0","endTime":"0","summary":"01. Lifecore Biomedical(LFCR.O)业绩电话会:2025年Q2,公司营收3260万美元,同比增长8%,毛利润1110万美元,增加110万美元,净亏损660万美元。上半年营收增长5%,毛利润增加380万美元,净亏损2280万美元。完成2430万美元股票发行,增强流动性。公司增长战略目标为12%营收复合年增长率,EBITDA利润率超25%。业务渠道增长,特别是大型跨国公司业务,占渠道的30%以上。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-06/doc-inecyrue8813194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFCR"],"gpt_icon":0},{"id":"2500111248","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨6.46%报7.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500111248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500111248?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914665,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分,Lifecore Biomedical, Inc.股票出现波动,股价快速拉升6.46%。Lifecore Biomedical, Inc.股票所在的制药行业中,整体涨幅为0.00%。其相关个股中,Scilex Holding Company C/Wts 10/11/2027 、Therapeuticsmd, Inc.、Cbdmd, Inc.涨幅较大,Painreform Ltd.、Therapeuticsmd, Inc.、Cbdmd, Inc.较为活跃,换手率分别为6.13%、5.43%、5.41%,振幅较大的相关个股有Therapeuticsmd, Inc.、Cbdmd, Inc.、Lifecore Biomedical, Inc.,振幅分别为9.03%、5.31%、4.80%。Lifecore Biomedical, Inc.公司简介:Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织,在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223105a2146897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223105a2146897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO","BK4212","LFCR","BK4121"],"gpt_icon":0},{"id":"2500907359","title":"Lifecore Biomedical(LFCR.US):2025年Q2财报实现营收3256.4万美元,前值为3015万美元,预期值为2975万美元;每股收益为-0.25美元,前值为0.39美元,预期值为-0.31美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500907359","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500907359?lang=zh_cn&edition=full","pubTime":"2025-01-03 05:23","pubTimestamp":1735853025,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical(LFCR.US):2025年Q2财报实现营收3256.4万美元,前值为3015万美元,预期值为2975万美元;每股收益为-0.25美元,前值为0.39美元,预期值为-0.31美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/03052347069557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LFCR"],"gpt_icon":0},{"id":"1129087770","title":"Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29),销售额$3260万高于预期$2975万","url":"https://stock-news.laohu8.com/highlight/detail?id=1129087770","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129087770?lang=zh_cn&edition=full","pubTime":"2025-01-03 05:08","pubTimestamp":1735852100,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical 报告季度每股亏损$,优于分析师普遍预期的$,差异率为13.79%。公司报告季度销售额为$3260万,超过分析师普遍预期的$2975万,差异率为9.59%。与去年同期的$3015万相比,这一销售额增长了8.13%。以上内容来自Benzinga Earnings专栏,原文如下:Lifecore Biomedical reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 13.79 percent. The company reported quarterly sales of $32.60 million which beat the analyst consensus estimate of $29.75 million by 9.59 percent. This is a 8.13 percent increase over sales of $30.15 million the same period last ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29),销售额$3260万高于预期$2975万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFCR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifecore.com","stockEarnings":[{"period":"1week","weight":-0.0269},{"period":"1month","weight":-0.0257},{"period":"3month","weight":0.1606},{"period":"6month","weight":-0.0117},{"period":"1year","weight":0.2067},{"period":"ytd","weight":-0.0721}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lifecore Biomedical, Inc.于1986年10月31日在加利福尼亚州注册成立,并于2008年11月6日重新注册为特拉华州公司。该公司及其子公司为食品和生物材料市场设计、开发、制造和销售差异化产品,并向合作伙伴许可技术应用。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.009627},{"month":2,"riseRate":0.448276,"avgChangeRate":-0.003394},{"month":3,"riseRate":0.633333,"avgChangeRate":0.027307},{"month":4,"riseRate":0.5,"avgChangeRate":0.010897},{"month":5,"riseRate":0.7,"avgChangeRate":0.050222},{"month":6,"riseRate":0.5,"avgChangeRate":0.004019},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.009675},{"month":8,"riseRate":0.5,"avgChangeRate":-0.000145},{"month":9,"riseRate":0.4,"avgChangeRate":0.003998},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.007015},{"month":11,"riseRate":0.5,"avgChangeRate":0.007022},{"month":12,"riseRate":0.533333,"avgChangeRate":0.010193}],"exchange":"NASDAQ","name":"LIFECORE BIOMEDICAL INC","nameEN":"LIFECORE BIOMEDICAL INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LIFECORE BIOMEDICAL INC(LFCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LIFECORE BIOMEDICAL INC,LFCR,LIFECORE BIOMEDICAL INC股票,LIFECORE BIOMEDICAL INC股票老虎,LIFECORE BIOMEDICAL INC股票老虎国际,LIFECORE BIOMEDICAL INC行情,LIFECORE BIOMEDICAL INC股票行情,LIFECORE BIOMEDICAL INC股价,LIFECORE BIOMEDICAL INC股市,LIFECORE BIOMEDICAL INC股票价格,LIFECORE BIOMEDICAL INC股票交易,LIFECORE BIOMEDICAL INC股票购买,LIFECORE BIOMEDICAL INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LIFECORE BIOMEDICAL INC(LFCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}